Insider · CIK 0001707827
Seshasayee Varadarajan
Files at LRCX (LAM RESEARCH CORP). First filing Mar 20, 2024, latest Sep 3, 2026.
In brief
Seshasayee Varadarajan files SEC Form 4 as officer at LRCX (LAM RESEARCH CORP). Since Mar 20, 2024, Seshasayee Varadarajan has reported 0 open-market buys worth $0 and 3 open-market sells worth $37M, the latest filed on Sep 3, 2026.
A track record needs three past buys with six months of prices behind them; Seshasayee Varadarajan has 0, so none is measured yet.
The newest scored trade: sold $17M of LRCX on Sep 2, 2026, filed Sep 3, 2026, scored 30 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $17M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LRCX: LAM RESEARCH CORP
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | LAM RESEARCH CORP | $17M 59,750 shares | -26% | - | |
| 25Weak | LAM RESEARCH CORP | $9.9M 110,080 shares | -51% | - | |
| 45Moderate | LAM RESEARCH CORP | $10M 11,000 shares | -40% | +93% from low-7% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 2, 2026 | LRCX LAM RESEARCH CORP | 59,750 0.00% of outstanding | $17M | Sep 2, 2026 | none |
| Feb 20, 2025 | LRCX LAM RESEARCH CORP | 110,080 0.01% of outstanding | $9.9M | Feb 20, 2025 | none |
| Mar 19, 2024 | LRCX LAM RESEARCH CORP | 5,500 0.00% of outstanding | $5.0M | Mar 19, 2024 | $5.1M |
| Mar 18, 2024 | LRCX LAM RESEARCH CORP | 5,500 0.00% of outstanding | $5.1M | Mar 18, 2024 | none |
Transactions
Every row this insider has filed, 40 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | LRCX LAM RESEARCH CORP | SOpen-market sale Common Stock10b5-1 | -20,000 | $291.32 | $5.8M | 205,546 | 41 d ago |
| Sep 2, 2026 | LRCX LAM RESEARCH CORP | MOption exercise Common Stock10b5-1 | +12,270 | $59.88 | $735k | 217,816 | 41 d ago |
| Sep 2, 2026 | LRCX LAM RESEARCH CORP | SOpen-market sale Common Stock10b5-1 | -12,270 | $291.32 | $3.6M | 205,546 | 41 d ago |
| Sep 2, 2026 | LRCX LAM RESEARCH CORP | MOption exercise Common Stock10b5-1 | +27,480 | $30.03 | $825k | 233,026 | 41 d ago |
| Sep 2, 2026 | LRCX LAM RESEARCH CORP | SOpen-market sale Common Stock10b5-1 | -27,480 | $291.32 | $8.0M | 205,546 | 41 d ago |
| Sep 2, 2026 | LRCX LAM RESEARCH CORP | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -12,270 | $0.00 | $0 | 0 | 41 d ago |
| Sep 2, 2026 | LRCX LAM RESEARCH CORP | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -27,480 | $0.00 | $0 | 0 | 41 d ago |
| Feb 27, 2026 | LRCX LAM RESEARCH CORP | AGrant or award Common Stock | +12,547 | $0.00 | $0 | 262,111 | Mar 2, 2026 |
| Feb 27, 2026 | LRCX LAM RESEARCH CORP | FTax withholding Common Stock | -26,126 | $233.89 | $6.1M | 235,985 | Mar 2, 2026 |
| Feb 27, 2026 | LRCX LAM RESEARCH CORP | FTax withholding Common Stock | -3,168 | $233.89 | $741k | 232,817 | Mar 2, 2026 |
| Feb 27, 2026 | LRCX LAM RESEARCH CORP | FTax withholding Common Stock | -2,572 | $233.89 | $602k | 230,245 | Mar 2, 2026 |
| Feb 27, 2026 | LRCX LAM RESEARCH CORP | FTax withholding Common Stock | -5,047 | $233.89 | $1.2M | 225,198 | Mar 2, 2026 |
| Feb 27, 2026 | LRCX LAM RESEARCH CORP | AGrant or award Market-based Performance Restricted Stock Unitderivative | +18,820 | $0.00 | $0 | 18,820 | Mar 2, 2026 |
| Feb 3, 2026 | LRCX LAM RESEARCH CORP | MOption exercise Common Stock | +53,925 | $0.00 | $0 | 249,564 | Feb 5, 2026 |
| Feb 3, 2026 | LRCX LAM RESEARCH CORP | MOption exercise Market-based Performance Restricted Stock Unitderivative | -35,950 | $0.00 | $0 | 0 | Feb 5, 2026 |
| Feb 28, 2025 | LRCX LAM RESEARCH CORP | AGrant or award Common Stock | +31,253 | $0.00 | $0 | 210,337 | Mar 4, 2025 |
| Feb 28, 2025 | LRCX LAM RESEARCH CORP | FTax withholding Common Stock | -7,045 | $76.74 | $541k | 203,292 | Mar 4, 2025 |
| Feb 28, 2025 | LRCX LAM RESEARCH CORP | FTax withholding Common Stock | -2,252 | $76.74 | $173k | 201,040 | Mar 4, 2025 |
| Feb 28, 2025 | LRCX LAM RESEARCH CORP | FTax withholding Common Stock | -3,168 | $76.74 | $243k | 197,872 | Mar 4, 2025 |
| Feb 28, 2025 | LRCX LAM RESEARCH CORP | FTax withholding Common Stock | -2,567 | $76.74 | $197k | 195,305 | Mar 4, 2025 |
| Feb 28, 2025 | LRCX LAM RESEARCH CORP | AGrant or award Market-based Performance Restricted Stock Unitderivative | +38,199 | $0.00 | $0 | 38,199 | Mar 4, 2025 |
| Feb 20, 2025 | LRCX LAM RESEARCH CORP | MOption exercise Common Stock10b5-1 | +35,760 | $19.01 | $680k | 214,844 | Feb 21, 2025 |
| Feb 20, 2025 | LRCX LAM RESEARCH CORP | SOpen-market sale Common Stock10b5-1 | -35,760 | $90.00 | $3.2M | 179,084 | Feb 21, 2025 |
| Feb 20, 2025 | LRCX LAM RESEARCH CORP | MOption exercise Common Stock10b5-1 | +74,320 | $17.68 | $1.3M | 253,404 | Feb 21, 2025 |
| Feb 20, 2025 | LRCX LAM RESEARCH CORP | SOpen-market sale Common Stock10b5-1 | -74,320 | $90.00 | $6.7M | 179,084 | Feb 21, 2025 |
| Feb 20, 2025 | LRCX LAM RESEARCH CORP | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -35,760 | $19.01 | $680k | 0 | Feb 21, 2025 |
| Feb 20, 2025 | LRCX LAM RESEARCH CORP | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -74,320 | $17.68 | $1.3M | 0 | Feb 21, 2025 |
| Feb 4, 2025 | LRCX LAM RESEARCH CORP | MOption exercise Common Stock | +14,542 | $0.00 | $0 | 179,084 | Feb 6, 2025 |
| Feb 4, 2025 | LRCX LAM RESEARCH CORP | MOption exercise Market-based Performance Restricted Stock Unitderivative | -25,540 | $0.00 | $0 | 0 | Feb 6, 2025 |
| Mar 18, 2024 | LRCX LAM RESEARCH CORP | SOpen-market sale Common Stock10b5-1 | -5,500 | $922.41 | $5.1M | 22,095 | Mar 20, 2024 |
| Mar 19, 2024 | LRCX LAM RESEARCH CORP | SOpen-market sale Common Stock10b5-1 | -5,500 | $913.99 | $5.0M | 16,595 | Mar 20, 2024 |
| Mar 1, 2024 | LRCX LAM RESEARCH CORP | AGrant or award Common Stock | +1,592 | $0.00 | $0 | 29,533 | Mar 5, 2024 |
| Mar 1, 2024 | LRCX LAM RESEARCH CORP | FTax withholding Common Stock | -1,134 | $981.53 | $1.1M | 28,399 | Mar 5, 2024 |
| Mar 1, 2024 | LRCX LAM RESEARCH CORP | FTax withholding Common Stock | -264 | $981.53 | $259k | 28,135 | Mar 5, 2024 |
| Mar 1, 2024 | LRCX LAM RESEARCH CORP | FTax withholding Common Stock | -224 | $981.53 | $220k | 27,911 | Mar 5, 2024 |
| Mar 1, 2024 | LRCX LAM RESEARCH CORP | FTax withholding Common Stock | -316 | $981.53 | $310k | 27,595 | Mar 5, 2024 |
| Mar 1, 2024 | LRCX LAM RESEARCH CORP | AGrant or award Market-based Performance Restricted Stock Unitderivative | +2,919 | $0.00 | $0 | 2,919 | Mar 5, 2024 |
| Mar 1, 2024 | LRCX LAM RESEARCH CORP | AGrant or award Employee Stock Option (Right to Buy)derivative | +2,388 | $0.00 | $0 | 2,388 | Mar 5, 2024 |
| Feb 6, 2024 | LRCX LAM RESEARCH CORP | MOption exercise Common Stock | +2,452 | $0.00 | $0 | 27,941 | Feb 8, 2024 |
| Feb 6, 2024 | LRCX LAM RESEARCH CORP | MOption exercise Market-based Performance Restricted Stock Unitderivative | -2,045 | $0.00 | $0 | 0 | Feb 8, 2024 |
Questions about Seshasayee Varadarajan
Answered from the filings on this page, as of the latest one.
Is Seshasayee Varadarajan buying or selling?
In the last 12 months Seshasayee Varadarajan reported 0 open-market buys worth $0 and 1 open-market sell worth $17M on SEC Form 4; the latest was sold $17M of LRCX on Sep 2, 2026. Grants, option exercises and tax withholding are not counted.
How did Seshasayee Varadarajan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Seshasayee Varadarajan has 0.
Where does Seshasayee Varadarajan file Form 4?
Seshasayee Varadarajan has filed Form 4 at LRCX (LAM RESEARCH CORP) as Senior Vice President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.